In a combination study of IL-12 and trastuzumab [73], IL-12 enhanced the FcγR-dependent immune response through IFN-γ produced by NK cells, thereby enhancing the anti-tumor effect of trastuzumab. This evidence concerns the gene IFNG and neoplasm.